ESG

Celebrating 135 years, Flor de Caña unveils a new bottle that's 18% lighter, reinforcing its commitment to sustainability without changing the spirit inside.

A new three-year agreement aims to make over 70% of Irish research free to read, but a closer look reveals the complex realities of open access.

New data on an oral Parkinson's drug and major strides in rare disease research signal Lundbeck's deep commitment to tackling complex neurological disorders.

Pure DC says it has fully decarbonized gas use at its Dublin site with biomethane. Is this a blueprint for green data or a controversial stopgap measure?

Swiss lab-tech firm Tecan posts a major loss after strategic write-downs but launches an ambitious 'Rewired' plan to chase a CHF 1B sales target.

The food distributor announces a planned CEO handover, positioning outgoing CEO Frank Grande to lead M&A and new CEO Joe Ward to drive operations.

Silvercrest Asset Management will report its 2025 results on March 17, with investors watching if record AUM growth can overcome rising costs and margin pressure.

Riyadh's KFSH performed 130 paired kidney transplants in 2025, the most by any single center worldwide, revolutionizing access to organ donation.

Bullion dealer SuisseGold now accepts USDT for physical metals, signaling a new era of digital finance meeting hard assets for global investors.

Facing a staggering $546M loss and a 'Selective Default' rating, specialty materials firm Trinseo shutters plants while betting on a green tech pivot.

A new report projects massive growth in cardiovascular devices, driven by AI and minimally invasive tech. But can the healthcare system afford this progress?

A new state-led cookbook, “Florida Flavors,” invites seniors to share treasured family recipes, preserving the state's rich culinary legacy for generations.

A partnership between Biophytis and LynxKite leverages AI to fast-track therapies for sarcopenia and macular degeneration, backed by Singapore's RIE 2030 plan.

As it advances its brain cancer therapies, NeOnc Technologies hires a public company finance expert to steer its next growth phase and ensure fiscal rigor.

As employers grapple with soaring obesity drug costs, a new partnership aims to offer predictable pricing and comprehensive care. Here's how it works.

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

New research reveals a major disconnect: consumers, led by Gen Z, crave sustainable dining, but the foodservice industry is struggling to keep up.

A new health tech platform is launching to turn movement into trackable, reimbursable medicine, bridging the gap between doctor's advice and patient action.

Hancom's OpenDataLoader PDF v2.0 promises top performance, on-premise security, and a roadmap to power the next generation of intelligent AI agents.

A new iPSC-derived cell therapy from Unixell Biotech has gained FDA approval for clinical trials, offering a regenerative approach for millions with epilepsy.